nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multi-center, open-label, randomized phase III trial of first-line chemotherapy with capecitabine monotherapy versus capecitabine plus oxaliplatin in elderly patients with advanced gastric cancer
|
Hwang, In Gyu |
|
2017 |
8 |
3 |
p. 170-175 6 p. |
artikel |
2 |
Assessment of older patients with cancer: Edmonton Frail Scale (EFS) as a predictor of adverse outcomes in older patients undergoing radiotherapy
|
Keenan, Lorna G. |
|
2017 |
8 |
3 |
p. 206-210 5 p. |
artikel |
3 |
Association between frailty and readmission within one year after gastrectomy in older patients with gastric cancer
|
Choe, Yu-Ri |
|
2017 |
8 |
3 |
p. 185-189 5 p. |
artikel |
4 |
Care for the caregivers
|
Ferrell, Betty |
|
2017 |
8 |
3 |
p. 160-161 2 p. |
artikel |
5 |
Editorial Board
|
|
|
2017 |
8 |
3 |
p. IFC- 1 p. |
artikel |
6 |
Enrollment of older adults on oncology trials: An FDA perspective
|
Singh, Harpreet |
|
2017 |
8 |
3 |
p. 149-150 2 p. |
artikel |
7 |
Functional decline in older patients with cancer receiving chemotherapy: A multicenter prospective study
|
Kenis, Cindy |
|
2017 |
8 |
3 |
p. 196-205 10 p. |
artikel |
8 |
Functional status decline in older patients with breast and colorectal cancer after cancer treatment: A prospective cohort study
|
van Abbema, Doris |
|
2017 |
8 |
3 |
p. 176-184 9 p. |
artikel |
9 |
Further psychometric validation of the GAH scale: Responsiveness and effect size
|
Cruz-Jentoft, Alfonso José |
|
2017 |
8 |
3 |
p. 211-215 5 p. |
artikel |
10 |
Immunotherapy comes of age: Immune aging & checkpoint inhibitors
|
Elias, Rawad |
|
2017 |
8 |
3 |
p. 229-235 7 p. |
artikel |
11 |
Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective Physical Frailty in Elderly Cancer patients (PF-EC) cohort study
|
Pamoukdjian, Frederic |
|
2017 |
8 |
3 |
p. 190-195 6 p. |
artikel |
12 |
Management of elderly patients suffering from cancer: Assessment of perceived burden and of quality of life of primary caregivers
|
Germain, Victor |
|
2017 |
8 |
3 |
p. 220-228 9 p. |
artikel |
13 |
Phase II study of dose-attenuated bortezomib, cyclophosphamide and dexamethasone (“VCD-Lite”) in very old or otherwise toxicity-vulnerable adults with newly diagnosed multiple myeloma
|
Tuchman, Sascha A. |
|
2017 |
8 |
3 |
p. 165-169 5 p. |
artikel |
14 |
Psychological stress in geriatric patients with genito-urinary cancers
|
Dräger, Désirée Louise |
|
2017 |
8 |
3 |
p. 216-219 4 p. |
artikel |
15 |
Regulatory considerations on the enrollment of older adults in oncology clinical trials
|
Raimi-Abraham, Bahijja Tolulope |
|
2017 |
8 |
3 |
p. 151-153 3 p. |
artikel |
16 |
Should you screen nursing home residents for cancer?
|
Rodin, Miriam B. |
|
2017 |
8 |
3 |
p. 154-159 6 p. |
artikel |
17 |
Study design for vulnerable older adults with multiple myeloma
|
Nathwani, Nitya |
|
2017 |
8 |
3 |
p. 162-164 3 p. |
artikel |